February 14, 2020
A sample of low-income patients engaged with Omada Health’s digital diabetes prevention program (DPP), achieved weight loss but no major difference in HbA1c levels after a year of use, according to study data recently highlighted by the company.
The results — published late last year in the CDC’s Preventing Chronic Disease journal and first previewed at a 2018 public health conference — suggest...
January 23, 2020
Employer health tech company Virgin Pulse has its eyes set on the diabetes space with the recent acquisition of digital therapeutic Blue Mesa Health, best known for its diabetes prevention program Transform. The financial details of the deal were not released.
Following the announcement, Blue Mesa Health’s technology will now be rolled into a new offering called Virgin Pulse Transform. The...
August 14, 2019
This morning Solera Health, a digital marketplace for benefits and chronic disease management programs, is offering a new Diabetes Prevention Program (DPP) in American Sign Language (ASL) to people in the Kansas City area.
The program, created by the Johnson County Department of Health and Environment, will service adults living with hearing impairments in the region who are covered by a local...
June 26, 2019
San Francisco-based digital chronic disease management company Omada Health has closed a $73 million funding round led by Wellington Management Company. Cigna Ventures, Andreessen Horowitz, U.S. Venture Partners, Norwest Venture Partners, Kaiser Permanente Ventures, Sanofi Ventures, Civilization Ventures and Providence Ventures also contributed.
WHAT THEY DO
Omada offers a slew of digital...
May 15, 2019
Solera Health, a digital marketplace for benefit and chronic disease management programs, has raised $42 million in a Series C round led by Health Care Service Corporation subsidy HCSC Ventures. Prior backers BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures participated as well.
WHAT THEY DO
Solera’s platform hosts a broad selection of digital...
November 14, 2018
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...
October 9, 2018
Health2047, a technology innovation enterprise backed the American Medical Association, announced today the launch of its second spin out company. Called First Mile Care, the new entity will use its $2 million in seed funding to build a scalable platform for connecting people with prediabetes to coaches and demographic-appropriate behavior change guidance.
First Mile Care’s platform is being...
September 18, 2018
Cigna and digital diabetes prevention program Omada Health are once again expanding their relationship, offering Omada's services to all of Cigna's regional and national employer customers, representing a significant portion of Cigna members.
"We will be expanding in January of this year to our national and regional clients, which is a large percentage of Cigna’s book of business, but it will be...
June 25, 2018
Working with digital diabetes prevention program (DPP) provider Omada Health — and combining that intervention with lab and biometric screenings — lab company Quest Diagnostics reduced risk for diabetes in one-third of a 107-employee cohort.
"Many employers are eager to implement employee wellness programs that drive better health and cost outcomes, but are unsure of how best to achieve these...
June 20, 2018
Digital chronic disease management company Omada Health announced today the launch of new programs designed to support individuals with Type 2 diabetes and hypertension.
Accompanying these are a set of new features for the enterprise and health plan platform focused on medication adherence and remote monitoring, all of which comprise what a representative from the company described as “the...